期刊文献+

RP-HPLC法测定不同溶剂和缓冲溶液中羟基喜树碱的溶解度 被引量:2

Determination of equilibrium solubilities of HCPT in different solvents and phosphate buffer solutions
下载PDF
导出
摘要 目的确定羟基喜树碱在不同溶剂和缓冲溶液中的平衡溶解度,为新型制剂的设计和制备奠定基础。方法采用高效液相色谱法测定羟基喜树碱在不同溶剂和缓冲溶液中的平衡溶解度。色谱条件:Diamonmsil-C18柱(4.6mm×250mm,5μm);流动相:甲醇-0.1mol/L磷酸盐缓冲液(60∶40),pH=5.0;流速:1mL/min;柱温:35℃;检测波长:384nm。结果首次确定了羟基喜树碱在16种溶剂和8种pH值的缓冲溶液中的溶解度。测定方法选择性较强,检测限为0.025mg/L,在0.050 6~10.120 0mg/L范围内峰面积与质量浓度呈良好的线性关系,精密度良好(RSD=0.13%),平均回收率为99.76%。结论测定结果为了解羟基喜树碱(HCPT)的理化性质及其新型制剂的设计和制备提供了科学依据,测定方法简便、迅速、准确。 Objective To determine equilibrium solubilities of HCPT in different solvents and phosphate buffer solutions which would settle fundament for the design and manufacture of a new dosage form. Methods HPLC was used to determine equilibrium solubilities (PBSs) of HCPT. HCPT was separated on Diamonsil-C18 column (4.6 mm× 250 mm, 5 μm) with methyl alcohol-0.1 mol/L phosphate buffer solution (60 : 40), pH= 5.0 as mobile phase. The flow rate was 1.0 mL/min and the detection wavelength was 384 nm. The column temperature was set at 35 ℃. Results The equilibrium solubilities of HCPT in 16 solvents and 8 PBSs with different pH values were gained firstly. The linear range for the content of HCPT was 0. 050 6-10. 120 0 mg/L. The recovery of HCPT was 99.76%, and its RSD was 0.13%. Conclusion The results in this study supplies a scientific reference for understanding the physicochemical properties of HCPT and the design and manufacture of its new dosage form. And the method was simple, rapid, and accurate.
出处 《河南大学学报(医学版)》 CAS 2012年第1期20-24,共5页 Journal of Henan University:Medical Science
关键词 羟基喜树碱 HPLC法 平衡溶解度 HCPT HPLC Equilibrium solubility
  • 相关文献

参考文献17

  • 1Wall M E,Wani M C,Cook C E. Plant Antitumor Agent Ⅰ:The isolation and structure of camptothecin a novel alkaloidal leukemia and tumor inhibitor from camptotheca acumianta[J].Journal of the American Chemical Society,1966,(16):3888-3890.doi:10.1021/ja00968a057.
  • 2Wall M E,Wani M C. Structure activity relationships of plant antitumor agents related to camptothecin and quassinoids[A].1981.125-149.
  • 3Hsiang T H,Liu L F. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin[J].Cancer Research,1988,(07):1722-1726.
  • 4Jaxel C,Kohn K W,Wani M C. Structure-acticvity study of the actions of camptothecin derivatives on mammalian topoisomerase Ⅰ:Evidence for a specific receptor site and for a relation to antitumor activity[J].Cancer Research,1989,(06):1465-1469.
  • 5OLeary J,Muggia F M. Camptothecins:a review of their development and schedules of administration[J].European Journal of Cancer,1998.1500-1508.
  • 6Carbonero R,Supko J. Current perspectives on the clinical experience pharmacology,and continued development of the camptothecins[J].Clinical Cancer Research,2002,(03):641-661.
  • 7滕南雁,蒋及年.HPLC测定羟基喜树碱及其注射液的含量[J].中国药学杂志,1997,32(9):552-553. 被引量:9
  • 8马锦星,孙仲葆,彭才勤,马烈.高效液相色谱法测定羟基喜树碱及喜树碱含量[J].中国药房,2001,12(3):172-173. 被引量:9
  • 9Ma M F,Tao Y U,Dai S J. Determination of contents of 10-Hydroxycamptothecin in camptotheca acuminate by high-performance liquid chromatogram[J].Journal of Forestry Research,2002,(02):144-146.doi:10.1007/BF02857241.
  • 10国家药典委员会.中华人民共和国药典[S]北京:化学工业出版社,2005附录XVD.

二级参考文献37

共引文献56

同被引文献35

  • 1陆彬.药物新剂型和新技术[M].2版.北京:人民卫生出版社,2005:384.
  • 2Del Hoyo C. , Applied Clay Science, 2007, 36(1-3) , 103-121.
  • 3Wani M. C. , Ronman P. E. , Lindley J. T. , Wall M. E. , J. Med. Chem. , 1980, 23(5), 554-560.
  • 4Jaxel C. , Kohn K. W. , Wani M. C. , Wall M. E. , Pommier Y. , Cancer Res. , 1989, 49(6), 1465-1469.
  • 5Gottlieb J. A. , Guarino A. M. , Call J. B. , Oliverio V. T. , Block J. B. , Cancer Chemother. Rep. , 1970, 54(6) , 461-470.
  • 6Bae Y. , Jang W. D. , Nishiyama N. , Fukushima S. , Kataoka K. , Molecular BioSystems, 2005, 1 (3), 242-250.
  • 7Kunadharaju S. , Savva M. , J. Chem. Thenrudyn, , 2008, 40(9) , 1439-1444.
  • 8Potmesil M. , Cancer Res. , 1994, 54(6) , 1431-1439.
  • 9LiF. S., JinL., HanJ. B., WeiM., LiC. J., Ind. Eng. Chem. Res.,2009,48(12),5590-5597.
  • 10Tyner K. M. , Schiffman S. R. , Giarmelis E. P. , J. Control. Release, 2004, 95(3) , 501-514.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部